1.
Chinese Journal of Geriatrics
; (12): 1337-1341, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-911014
ABSTRACT
Systemic light-chain(AL)amyloidosis has an insidious onset and diverse clinical manifestations with high early mortality and can be easily overlooked or misdiagnosed in the elderly.Early diagnosis and deep remission are critical for the long-term survival of AL amyloidosis patients.This article provides a systematic review of the current status of treatment and progress in new drugs for AL amyloidosis.